跳至主要内容
临床试验/NCT07373379
NCT07373379尚未招募不适用

Effectiveness and Implementation of an AI-Driven Blended Care Model for Type 2 Diabetes Management in Primary Care: A Single-Blind, Cluster Randomized Controlled Trial in Zhangjiagang, China

Peking University0 个研究点目标入组 1,200 人开始时间: 2026年3月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
1,200
主要终点
Change in Glycosylated Hemoglobin (HbA1c) Levels

研究概览

简要总结

The goal of this cluster randomized clinical trial is to learn if an AI-enabled blended care model (the BRIDGE program) works to treat type 2 diabetes in adults. It will also learn about the cost-effectiveness and implementation feasibility of this model in primary care settings. The main questions it aims to answer are:

Does the AI-driven intervention lower HbA1c levels (blood sugar) compared to standard care?

Does this model improve participants' quality of life, self-management behaviors, and digital literacy?

Researchers will compare the "Diet-Medicine Companion" (Shi Yi Ban Lv) mini-program combined with family doctor support to standard community care to see if the blended care model works to manage diabetes.

Participants will:

Use the "Diet-Medicine Companion" mini-program to upload diet photos daily and receive AI feedback for 6 months

Receive periodic guidance and phone reminders from case administrators (family doctors)

Complete questionnaires and blood tests (HbA1c) at baseline, 3 months, and 6 months

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Aged 18 to 70 years (inclusive).
  • Glycosylated hemoglobin (HbA1c) level ≥ 6.5%.
  • Resided in the local area for at least 6 months.
  • Capable of using a smartphone to take photos and use the WeChat mini-program.
  • Willing and able to provide informed consent.

排除标准

  • Diagnosed with Type 1 diabetes, gestational diabetes, or secondary diabetes.
  • Presence of severe diabetic complications.
  • Received radiotherapy or chemotherapy within the past 6 months.
  • Diagnosed with severe intellectual disabilities, Alzheimer's disease, or other serious psychiatric disorders.
  • Current participation in other research projects that may affect the results of this study.
  • Presence of other severe disabilities or medical conditions deemed unsuitable for participation by the investigators.

研究组 & 干预措施

Intervention

Experimental

Participants in this arm will receive the "Diet-Medicine Companion" (Shi Yi Ban Lv) intervention. This involves using an AI-powered WeChat mini-program for daily dietary logging and receiving real-time feedback. Participants also receive proactive monitoring and support from family doctors (case administrators), including telephone reminders if they are inactive for more than 7 days and targeted health guidance based on their data.

干预措施: AI-driven Dietary Management and Human-in-the-loop Support (Device)

Control

No Intervention

Participants in this arm will receive standard community care (usual care) for type 2 diabetes management provided by their local community health centers. They will complete the same schedule of assessments (HbA1c tests and questionnaires) at baseline, 3 months, and 6 months but will not receive the AI mini-program intervention or the specific case administrator support provided to the experimental group.

结局指标

主要结局

Change in Glycosylated Hemoglobin (HbA1c) Levels

时间窗: Baseline, Month 3, and Month 6

Glycosylated Hemoglobin (HbA1c) reflects the average plasma glucose concentration over the preceding 3 months. It serves as the gold standard biomarker for long-term glycemic control in diabetes management. Data will be obtained from venous blood samples collected at community health centers. A lower HbA1c percentage indicates better glycemic control.

次要结局

  • Change in Body Mass Index (BMI)(Baseline, Month 3, and Month 6)
  • Change in Blood Pressure(Baseline, Month 3, and Month 6)
  • Incidence of Diabetes Complications(Baseline, Month 3, and Month 6)
  • Quality of Life (EQ-5D-5L)(Baseline, Month 3, and Month 6)
  • Self-Management Behaviors (SDSCA)(Baseline, Month 3, and Month 6)
  • Treatment Satisfaction (DTSQs)(Baseline, Month 3, and Month 6)
  • Digital Literacy (C-eHEALS)(Baseline, Month 3, and Month 6)
  • Medical Costs(Baseline, Month 3, and Month 6)

研究者

发起方
Peking University
申办方类型
Other
责任方
Sponsor

相似试验

Blended Resources for Integrated Diabetes Guidance... | 临床试验